Market News & Trends
Bristol-Myers Squibb to Expand, Build Cancer Research Hub
Bristol-Myers Squibb Co. recently announced it has taken the first steps toward expanding its office space and building a cancer research hub for drugs that…
Horizon Discovery & Otsuka Sign Collaboration Agreement
Horizon Discovery Group plc recently announced its Horizon CombinatoRx division has been contracted by Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) to perform in vitro…
West Expands Presence in Asian Markets
West Pharmaceutical Services, Inc. has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary…
Mystic Pharmaceuticals Unveils Next Generation of Patient-Centric Sublingual Delivery Devices
Mystic Pharmaceuticals, Inc. recently announced the availability of its Javelin Sublingual drug delivery devices. Javelin Sublingual dispensers utilized Mystic’s VersiDoser and VRx2 platform technology, and…
Immatics Receives Almost $30-Million Final Tranche of Series D Funding
Immatics Biotechnologies GmbH recently announced it has received €22m (almost $30 million) to complete a Series D financing round. The company received €12m in October…
Hovione & Merrion Pharmaceuticals Announce Strategic Partnership
Hovione and Merrion Pharmaceuticals recently announced they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione…
Shimadzu Seeks to Redefine Quantitative Proteomics
Shimadzu Corporation recently announced the release of the new mutual support between the Skyline quantitative proteomics software and Shimadzu's high-sensitivity triple quadrupole LC/MS/MS platform. As…
Actinium Initiates Development of Antibody for Hematologic Malignancies
Actinium Pharmaceuticals, Inc. initiated development of an additional antibody construct labeled with actinium-225. The antibody has potential to be used in treatment of a number…
Incyte Achieves $25-Million Milestone for Jakavi Approval
Incyte Corporation announced it has earned a $25-million milestone payment from Novartis in connection with the approval of Jakavi (ruxolitinib) in Japan for the treatment…
Protea Biosciences & InSphero AG Enter to Combine 3D Technologies
Protea Biosciences Group, Inc. and InSphero AG jointly announced they have entered into a collaboration that will combine each company's respective 3D technology. InSphero AG…
Oral Octreotide Could Capture a Share of Injectables Market
Recent trials exhibiting the effectiveness of oral octreotide for treating acromegaly may be a cause of concern for injectable somatostatin analogs (SSAs), providing that the…
Concept Life Sciences Creates UK-Based $100-Million Life Sciences Group
Concept Life Sciences, a newly formed international scientific laboratory and consultancy business, has made three acquisitions with a combined enterprise value approaching $100 million. The…
Logan Instruments Showcases Latest Automation System
This week, Logan Instruments Corp. is exhibiting at the CRS Annual Meeting in Chicago, IL. A leader in pharmaceutical testing instrumentation, Logan Instruments Corp. released…
AAIPharma & Cambridge Major Laboratories Announce New CEO
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. recently announced the appointment of Stephan Kutzer, PhD, as CEO, effective August 1, 2014. “AAIPharma and Cambridge…
Inhalation Technology: A Breath of Fresh Air in Drug Delivery!
CLICK HERE TO DOWNLOAD/VIEW DOCUMENT
Vcaps® Plus Capsules: A New HPMC Capsule for Optimum Formulation
CLICK HERE TO VIEW/DOWNLOAD DOCUMENT
A Tough Pill to Swallow
A Tough Pill to Swallow Patient preference and compliance are becoming increasingly important differentiators in a crowded pharmaceutical marketplace. To achieve effective product positioning and…
Constantia Flexibles Introduces Deep-Drawn Aluminum Container for Pharmaceutical Devices
Constantia Flexibles has developed a new deep-drawn aluminum container for pharmaceutical devices. Known as Constantia Safemax, the innovation offers dramatic improvement over traditional packaging in…
D3 Medicine & Viroclinicas Biosciences Sign Collaboration
d3 Medicine LLC and Viroclinics Biosciences BV recently announced they have signed a non-exclusive Memorandum of Understanding to provide biopharmaceutical customers with an integrated solution…
PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions
PolyPid recently announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for US application Serial No. 13/574,040, a…
